Zura Bio Limited (ZURA)
ZURA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.23
+5.75% on the day
Market cap
$405.4M
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ZURA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Cayman Islands |
| IPO year | Not reported by the screener |
| SEC CIK | 0001855644 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | E9 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-02-25 |
| Latest annual report | 10-K | 2026-03-19 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report FORM 8-K | 8-K | 2026-08-17 |
| Latest proxy | DEFA14A | 2026-05-22 |
Source: SEC EDGAR submissions feed, 442 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.2% |
| 1 month | -13.6% |
| 3 months | -18.9% |
| Year to date | -18.7% |
| 1 year | +10.4% |
| From 52-week high | -39.5% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TECX | Tectonic Therapeutic Inc. | $21.31 | -4.65% | $416.6M |
| AUTL | Autolus Therapeutics plc American Depositary Share | $1.62 | -6.90% | $431.2M |
| ENTX | Entera Bio Ltd. | $2.49 | -6.04% | $433.1M |
| AGMB | AgomAb Therapeutics NV | $8.81 | -3.08% | $433.9M |
| EDIT | Editas Medicine Inc. | $2.44 | -11.09% | $375.5M |
| TRXB | TRex Bio Inc. | $13.60 | -3.06% | $373.3M |
| ALLO | Allogene Therapeutics Inc. | $1.29 | -7.86% | $445.7M |
| EIKN | Eikon Therapeutics Inc. | $6.72 | -7.44% | $364.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier